Compositions and methods for treating retinal degradation
US10864212B2 · kind B2 · utility
5Cited by
8References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 2019 |
| Grant date | Dec 15, 2020 |
| Priority date | — |
| Expiry date | Mar 22, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compositions and methods for treating retinal damage and/or retinal degradation. More specifically, this disclosure relates to methods for treating degradation of the retinal pigment epithelium by administering compositions comprising a nucleoside and/or a nucleoside or nucleotide reverse transcriptase inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.